Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
key details
| Value | £975,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 +8 more |
| Region | London |
| Deadline | 5 Jan 2022 |
| Procedure | open |
| OCID | ocds-h6vhtk-02f911 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Sharp Clinical Services (UK) Ltd | · | · | active |
description
Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.
Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).
Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 22 Nov 2021 | Contract notice (F02) | Earlier regulations | 029090-2021 |
| 21 Aug 2023 | Contract award notice (F03) | Earlier regulations | 024521-2023 |
more from London School of Hygiene & Tropical Medicine
- Insurance Service · 3 Jun 2025
- In Vivo Imaging System - Maintenance · 20 Feb 2025
- Asbestos - Management & Testing · £150,000 · 15 Nov 2024
- Student Case Management Solution · £70,000 · 11 Nov 2024
- Occupational Health Service · 10 Oct 2024
- Research Grants Management System · 9 Oct 2024
- IMP Manufacture, Labelling and Packaging DPS · £15,000,000 · 23 Aug 2024
- Service and Maintenance of Safety and Fume Cabinets · £125,000 · 8 Aug 2024
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.